Super-Potent Drug: Out of specification potency results were obtained.
Mylan Institutional
Super-Potent Drug: Out of specification potency results were obtained.
Subpotent and Superpotent Drug
Subpotent and Superpotent Drug
Subpotent and Superpotent Drug
Subpotent and Superpotent Drug
Subpotent and Superpotent Drug
Subpotent and Superpotent Drug
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Presence of Particulate Matter
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Presence of Particulate Matter: particulate matter identified as copper salts
Presence of Particulate Matter
Presence of Particulate Matter
Presence of Particulate Matter
Presence of Particulate Matter
Presence of Particulate Matter
Presence of Particulate Matter
Lack of Assurance of Sterility; due to leaking vials
Lack of Assurance of Sterility; due to leaking vials
Subpotent Drug and Failed Impurities/Degradation Specifications
Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL